Blood biomarkers of brain injury after cardiac arrest- a dynamic field.

[1]  N. Lundbom,et al.  Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial , 2020, Intensive Care Medicine.

[2]  A. Cohen-Solal,et al.  Protein S100B as a reliable tool for early prognostication after cardiac arrest. , 2020, Resuscitation.

[3]  M. Wise,et al.  Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients. , 2020, Resuscitation.

[4]  T. Hortobágyi,et al.  An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders , 2020, Nature Reviews Neurology.

[5]  S. Hyun,et al.  Combination of S100B and procalcitonin improves prognostic performance compared to either alone in patients with cardiac arrest , 2019, Medicine.

[6]  Philip S. Insel,et al.  Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest , 2019, JAMA neurology.

[7]  J. Ornato,et al.  Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study , 2018, The Lancet Neurology.

[8]  Philip S. Insel,et al.  Serum tau and neurological outcome in cardiac arrest , 2017, Annals of neurology.

[9]  C. Ploner,et al.  Neuron-Specific Enolase Predicts Poor Outcome After Cardiac Arrest and Targeted Temperature Management: A Multicenter Study on 1,053 Patients , 2017, Critical care medicine.

[10]  M. Wise,et al.  Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 °C and 36 °C , 2017, Critical Care.

[11]  K. Blennow,et al.  Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing‐remitting multiple sclerosis , 2017, Journal of neurochemistry.

[12]  Henrik Zetterberg,et al.  Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa , 2016, Clinical chemistry and laboratory medicine.

[13]  K. Park,et al.  Use of S-100B, NSE, CRP and ESR to predict neurological outcomes in patients with return of spontaneous circulation and treated with hypothermia , 2016, Emergency Medicine Journal.

[14]  J. Soar,et al.  European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for Post-resuscitation Care 2015: Section 5 of the European Resuscitation Council Guidelines for Resuscitation 2015. , 2015, Resuscitation.

[15]  M. Wise,et al.  Neuron-Speci fi c Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest and Targeted Temperature Management at 33 C and 36 C , 2015 .

[16]  E. Hol,et al.  Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. , 2015, Current opinion in cell biology.

[17]  H. Zetterberg,et al.  Post-cardiac arrest serum levels of glial fibrillary acidic protein for predicting neurological outcome. , 2014, Resuscitation.

[18]  H. Figulla,et al.  Hypothermia after cardiac arrest does not affect serum levels of neuron‐specific enolase and protein S‐100b , 2014, Acta anaesthesiologica Scandinavica.

[19]  C. Callaway,et al.  Combining NSE and S100B with clinical examination findings to predict survival after resuscitation from cardiac arrest. , 2014, Resuscitation.

[20]  M. Wise,et al.  Targeted temperature management at 33°C versus 36°C after cardiac arrest. , 2013, The New England journal of medicine.

[21]  Henrik Zetterberg,et al.  Tau proteins in serum predict neurological outcome after hypoxic brain injury from cardiac arrest: results of a pilot study. , 2013, Resuscitation.

[22]  R. Donato,et al.  Functions of S100 proteins. , 2012, Current molecular medicine.

[23]  S. Einav,et al.  Modeling serum biomarkers S100 beta and neuron-specific enolase as predictors of outcome after out-of-hospital cardiac arrest: an aid to clinical decision making. , 2012, Journal of the American College of Cardiology.

[24]  T. Cronberg,et al.  Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia. , 2009, Resuscitation.

[25]  H. Sigusch,et al.  Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale. , 2005, Resuscitation.

[26]  V. Pettilä,et al.  Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With Hypothermia , 2003, Stroke.

[27]  J. Nielsen,et al.  Neuron-specific enolase and S-100b in prolonged targeted temperature management after cardiac arrest: A randomised study. , 2018, Resuscitation.